SEC Form 4 |
Date |
Sym |
Company |
Insider |
Title |
Shares |
Transaction |
Value |
|---|---|---|---|---|---|---|---|---|
May 13 2013 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 29,363 | Sale at $8.34 | $244,887 | |
Apr 5 2013 | KERX | Keryx Biopharmaceuticals Inc | Bentsur Ron | CEO | 1,795 | Sale at $6.93 | $12,439 | |
Apr 5 2013 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 1,484 | Sale at $6.93 | $10,284 | |
Mar 27 2013 | KERX | Keryx Biopharmaceuticals Inc | Bentsur Ron | CEO | 31,231 | Sale at $6.88 | $214,869 | |
MJun 27 2012 | KERX | Keryx Biopharmaceuticals Inc | Kaye Jack | Director | 10,000 | Gift at $1.81 | $18,100 | |
Jan 2 2013 | KERX | Keryx Biopharmaceuticals Inc | Bentsur Ron | CEO | 25,000 | Grant at $0.00 | $0 | |
Jan 4 2013 | KERX | Keryx Biopharmaceuticals Inc | Bentsur Ron | CEO | 6,010 | Sale at $2.74 | $16,467 | |
Jan 2 2013 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 33,520 | Grant at $0.00 | $0 | |
Jan 4 2013 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 10,859 | Sale at $2.74 | $29,754 | |
Oct 3 2012 | KERX | Keryx Biopharmaceuticals Inc | Bentsur Ron | CEO | 746 | Sale at $2.72 | $2,029 | |
Oct 3 2012 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 4,973 | Sale at $2.72 | $13,527 | |
Jul 3 2012 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 4,559 | Sale at $1.99 | $9,072 | |
Jul 3 2012 | KERX | Keryx Biopharmaceuticals Inc | Bentsur Ron | CEO | 684 | Sale at $1.99 | $1,361 | |
Jun 20 2012 | KERX | Keryx Biopharmaceuticals Inc | Kaye Jack | Director | 15,000 | Grant at $0.00 | $0 | |
Jun 20 2012 | KERX | Keryx Biopharmaceuticals Inc | Fowler Wyche Jr | Director | 15,000 | Grant at $0.00 | $0 | |
Jun 20 2012 | KERX | Keryx Biopharmaceuticals Inc | Feczko Joseph M | Director | 15,000 | Grant at $0.00 | $0 | |
Jun 20 2012 | KERX | Keryx Biopharmaceuticals Inc | Cameron Kevin J | Director | 15,000 | Grant at $0.00 | $0 | |
Jun 20 2012 | KERX | Keryx Biopharmaceuticals Inc | Tarnok Michael P. | Director | 15,000 | Grant at $0.00 | $0 | |
May 21 2012 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 400,000 | Grant at $0.00 | $0 | |
MApr 18 2012 | KERX | Keryx Biopharmaceuticals Inc | Bentsur Ron | CEO | 19,100 | Purchase at $1.30 | $24,773 | |
Apr 5 2012 | KERX | Keryx Biopharmaceuticals Inc | Feczko Joseph M | Director | 20,000 | Purchase at $1.62 | $32,400 | |
Apr 5 2012 | KERX | Keryx Biopharmaceuticals Inc | Tarnok Michael P. | Director | 17,500 | Purchase at $1.55 | $27,125 | |
Apr 5 2012 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 5,458 | Sale at $1.60 | $8,738 | |
Apr 4 2012 | KERX | Keryx Biopharmaceuticals Inc | Bentsur Ron | CEO | 71,400 | Purchase at $1.38 | $98,525 | |
Jan 3 2012 | KERX | Keryx Biopharmaceuticals Inc | Kaye Jack | Director | 9,720 | Gift at $2.65 | $25,758 | |
Jan 2 2012 | KERX | Keryx Biopharmaceuticals Inc | Bentsur Ron | CEO | 33,000 | Grant at $0.00 | $0 | |
Jan 3 2012 | KERX | Keryx Biopharmaceuticals Inc | Bentsur Ron | CEO | 3,305 | Sale at $2.62 | $8,676 | |
Jan 2 2012 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 28,000 | Grant at $0.00 | $0 | |
Jan 3 2012 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 7,190 | Sale at $2.62 | $18,874 | |
Dec 15 2011 | KERX | Keryx Biopharmaceuticals Inc | Kaye Jack | Director | 86,680 | Gift at $2.42 | $209,766 | |
Oct 3 2011 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 6,105 | Sale at $2.82 | $17,192 | |
Aug 10 2011 | KERX | Keryx Biopharmaceuticals Inc | Fowler Wyche Jr | Director | 5,000 | Purchase at $3.07 | $15,345 | |
Aug 10 2011 | KERX | Keryx Biopharmaceuticals Inc | Feczko Joseph M | Director | 10,000 | Purchase at $3.09 | $30,900 | |
Aug 10 2011 | KERX | Keryx Biopharmaceuticals Inc | Tarnok Michael P. | Director | 15,000 | Purchase at $3.10 | $46,500 | |
MAug 10 2011 | KERX | Keryx Biopharmaceuticals Inc | Bentsur Ron | CEO | 7,500 | Purchase at $3.05 | $22,905 | |
Jun 22 2011 | KERX | Keryx Biopharmaceuticals Inc | Tarnok Michael P. | Director | 15,000 | Grant at $0.00 | $0 | |
Jun 22 2011 | KERX | Keryx Biopharmaceuticals Inc | Kaye Jack | Director | 15,000 | Grant at $0.00 | $0 | |
Jun 22 2011 | KERX | Keryx Biopharmaceuticals Inc | Fowler Wyche Jr | Director | 15,000 | Grant at $0.00 | $0 | |
Jun 22 2011 | KERX | Keryx Biopharmaceuticals Inc | Feczko Joseph M | Director | 15,000 | Grant at $0.00 | $0 | |
Jun 22 2011 | KERX | Keryx Biopharmaceuticals Inc | Cameron Kevin J | Director | 15,000 | Grant at $0.00 | $0 | |
Jul 5 2011 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 4,611 | Sale at $4.80 | $22,133 | |
Jun 6 2011 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 47,231 | Sale at $4.99 | $235,683 | |
Apr 5 2011 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 4,490 | Sale at $5.10 | $22,899 | |
Mar 24 2011 | KERX | Keryx Biopharmaceuticals Inc | Bentsur Ron | CEO | 28,791 | Sale at $4.78 | $137,621 | |
Mar 22 2011 | KERX | Keryx Biopharmaceuticals Inc | Feczko Joseph M | Director | 20,000 | Purchase at $4.34 | $86,800 | |
Jan 2 2011 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 16,250 | Grant at $0.00 | $0 | |
Jan 3 2011 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 14,064 | Sale at $4.67 | $65,679 | |
Jan 2 2011 | KERX | Keryx Biopharmaceuticals Inc | Bentsur Ron | CEO | 25,000 | Grant at $0.00 | $0 | |
Dec 6 2010 | KERX | Keryx Biopharmaceuticals Inc | Kaye Jack | Director | 20,000 | Sale at $5.00 | $100,000 | |
MDec 2 2010 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 135,373 | Sale at $5.02 | $679,390 | |
MDec 2 2010 | KERX | Keryx Biopharmaceuticals Inc | Bentsur Ron | CEO | 255,560 | Sale at $5.04 | $1,288,578 | |
Oct 4 2010 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 1,209 | Sale at $4.58 | $5,537 | |
Sep 29 2010 | KERX | Keryx Biopharmaceuticals Inc | Kaye Jack | Director | 25,000 | Sale at $5.02 | $125,500 | |
Aug 20 2010 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 10,000 | Sale at $3.84 | $38,400 | |
Jul 6 2010 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 1,213 | Sale at $3.35 | $4,064 | |
Jun 16 2010 | KERX | Keryx Biopharmaceuticals Inc | Fowler Wyche Jr | Director | 15,000 | Grant at $0.00 | $0 | |
Jun 16 2010 | KERX | Keryx Biopharmaceuticals Inc | Cameron Kevin J | Director | 15,000 | Grant at $0.00 | $0 | |
Jun 16 2010 | KERX | Keryx Biopharmaceuticals Inc | Kaye Jack | Director | 15,000 | Grant at $0.00 | $0 | |
Jun 16 2010 | KERX | Keryx Biopharmaceuticals Inc | Tarnok Michael P. | Director | 15,000 | Grant at $0.00 | $0 | |
Jun 8 2010 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 41,497 | Sale at $3.96 | $164,536 | |
May 12 2010 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 31,667 | Option exercise at $2.14 | $67,767 | |
May 12 2010 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 60,000 | Sale at $6.26 | $375,600 | |
MApr 23 2010 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | 10% Owner | 627,649 | Sale at $5.40 | $3,389,995 | |
MApr 5 2010 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | 10% Owner | 460,200 | Sale at $3.81 | $1,753,038 | |
MApr 5 2010 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | 10% Owner | 350,000 | Option exercise at $1.30 | $455,000 | |
Apr 5 2010 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 899 | Sale at $3.36 | $3,021 | |
Mar 23 2010 | KERX | Keryx Biopharmaceuticals Inc | Bentsur Ron | CEO | 250,000 | Grant at $0.00 | $0 | |
Mar 24 2010 | KERX | Keryx Biopharmaceuticals Inc | Bentsur Ron | CEO | 31,089 | Sale at $2.95 | $91,713 | |
Jan 2 2010 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 100,000 | Grant at $0.00 | $0 | |
Jan 5 2010 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 22,981 | Sale at $2.60 | $59,771 | |
Dec 18 2009 | KERX | Keryx Biopharmaceuticals Inc | Fowler Wyche Jr | Director | 10,000 | Purchase at $2.54 | $25,419 | |
Dec 16 2009 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 5,214 | Grant at $0.00 | $0 | |
Sep 22 2009 | KERX | Keryx Biopharmaceuticals Inc | Bentsur Ron | CEO | 100,000 | Grant at $0.00 | $0 | |
Jun 23 2009 | KERX | Keryx Biopharmaceuticals Inc | Bentsur Ron | CEO | 5,560 | Purchase at $0.90 | $4,997 | |
Jun 23 2009 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 2,750 | Purchase at $0.90 | $2,472 | |
Jun 16 2009 | KERX | Keryx Biopharmaceuticals Inc | Kaye Jack | Director | 75,000 | Grant at $0.00 | $0 | |
Jun 16 2009 | KERX | Keryx Biopharmaceuticals Inc | Cameron Kevin J | Director | 10,000 | Grant at $0.00 | $0 | |
Jun 16 2009 | KERX | Keryx Biopharmaceuticals Inc | Tarnok Michael P. | Director | 25,000 | Grant at $0.00 | $0 | |
Jun 4 2009 | KERX | Keryx Biopharmaceuticals Inc | Fowler Wyche Jr | Director | 20,000 | Purchase at $1.05 | $21,000 | |
May 26 2009 | KERX | Keryx Biopharmaceuticals Inc | Tarnok Michael P. | Director | 40,000 | Purchase at $0.46 | $18,400 | |
May 22 2009 | KERX | Keryx Biopharmaceuticals Inc | Kaye Jack | Director | 35,000 | Purchase at $0.43 | $15,015 | |
May 22 2009 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | CFO | 25,000 | Purchase at $0.40 | $9,925 | |
MMay 22 2009 | KERX | Keryx Biopharmaceuticals Inc | Bentsur Ron | CEO | 80,000 | Purchase at $0.37 | $29,767 | |
Apr 29 2009 | KERX | Keryx Biopharmaceuticals Inc | Tarnok Michael P. | Interim CEO | 100,000 | Grant at $0.00 | $0 | |
Jan 2 2009 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | VP, Finance | 50,000 | Grant at $0.00 | $0 | |
Dec 19 2008 | KERX | Keryx Biopharmaceuticals Inc | Fowler Wyche Jr | Director | 3,000 | Sale at $0.21 | $630 | |
Nov 14 2008 | KERX | Keryx Biopharmaceuticals Inc | Cameron Kevin J | Director | 60,000 | Grant at $0.00 | $0 | |
Nov 14 2008 | KERX | Keryx Biopharmaceuticals Inc | Fowler Wyche Jr | Director | 60,000 | Grant at $0.00 | $0 | |
Nov 14 2008 | KERX | Keryx Biopharmaceuticals Inc | Hoenlein Malcolm | Director | 110,000 | Grant at $0.00 | $0 | |
Nov 14 2008 | KERX | Keryx Biopharmaceuticals Inc | Kaye Jack | Director | 60,000 | Grant at $0.00 | $0 | |
Nov 14 2008 | KERX | Keryx Biopharmaceuticals Inc | Rose Eric A Md | Director | 155,000 | Grant at $0.00 | $0 | |
Nov 14 2008 | KERX | Keryx Biopharmaceuticals Inc | Tarnok Michael P. | Director | 50,000 | Grant at $0.00 | $0 | |
Nov 14 2008 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | CEO | 1,800,000 | Grant at $0.00 | $0 | |
MAug 22 2008 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | CEO | 150,000 | Purchase at $0.40 | $60,500 | |
Aug 14 2008 | KERX | Keryx Biopharmaceuticals Inc | Oliviero James F III | VP Finance | 280,000 | Grant at $0.00 | $0 | |
Nov 19 2007 | KERX | Keryx Biopharmaceuticals Inc | Tarnok Michael P. | Director | 1,100 | Purchase at $8.71 | $9,581 | |
Sep 28 2007 | KERX | Keryx Biopharmaceuticals Inc | Fowler Wyche Jr | Director | 3,000 | Purchase at $10.06 | $30,180 | |
Jun 19 2007 | KERX | Keryx Biopharmaceuticals Inc | Kaye Jack | Director | 1,400 | Purchase at $10.50 | $14,699 | |
Jun 18 2007 | KERX | Keryx Biopharmaceuticals Inc | Levine Beth F | General Counsel, CCO | 1,000 | Purchase at $11.00 | $11,000 | |
MJun 7 2007 | KERX | Keryx Biopharmaceuticals Inc | Stier Mark | Chief Accounting Officer | 2,500 | Purchase at $10.77 | $26,913 | |
Apr 25 2007 | KERX | Keryx Biopharmaceuticals Inc | Henderson Craig | President | 150,000 | Grant at $0.00 | $0 | |
Apr 25 2007 | KERX | Keryx Biopharmaceuticals Inc | Henderson Craig | President | 17,875 | Option payment at $11.02 | $196,983 | |
Feb 14 2007 | KERX | Keryx Biopharmaceuticals Inc | Renaud Ronald C Jr | CFO | 5,973 | Option payment at $11.79 | $70,422 | |
Dec 29 2006 | KERX | Keryx Biopharmaceuticals Inc | Hoenlein Malcolm | Director | 5,000 | Option exercise at $1.92 | $9,600 | |
MDec 29 2006 | KERX | Keryx Biopharmaceuticals Inc | Hoenlein Malcolm | Director | 7,000 | Sale at $13.23 | $92,620 | |
MDec 15 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 37,344 | Option exercise at $1.30 | $48,547 | |
MDec 15 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 37,344 | Sale at $14.03 | $523,871 | |
MDec 12 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 59,224 | Option exercise at $1.30 | $76,991 | |
MDec 12 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 59,224 | Sale at $14.31 | $847,570 | |
MDec 11 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 18,500 | Sale at $14.47 | $267,640 | |
MDec 7 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 103,432 | Option exercise at $1.30 | $134,462 | |
MDec 7 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 84,932 | Sale at $14.59 | $1,239,133 | |
Jul 18 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 10,000 | Option exercise at $1.30 | $13,000 | |
MJul 18 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 10,000 | Sale at $11.61 | $116,098 | |
Jun 20 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 40,000 | Option exercise at $1.30 | $52,000 | |
MJun 20 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 40,000 | Sale at $12.61 | $504,547 | |
May 22 2006 | KERX | Keryx Biopharmaceuticals Inc | Rosenwald Lindsay A Md | Director | 1,000,000 | Gift at $0.00 | $0 | |
May 16 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 40,000 | Option exercise at $1.30 | $52,000 | |
MMay 16 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 40,000 | Sale at $15.32 | $612,933 | |
Apr 18 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chariman, CEO | 40,000 | Option exercise at $1.30 | $52,000 | |
MApr 18 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chariman, CEO | 40,000 | Sale at $17.09 | $683,472 | |
Mar 29 2006 | KERX | Keryx Biopharmaceuticals Inc | Bentsur Ron | Chief Accounting Officer | 35,000 | Option exercise at $1.10 | $38,500 | |
MMar 29 2006 | KERX | Keryx Biopharmaceuticals Inc | Bentsur Ron | Chief Accounting Officer | 35,000 | Sale at $18.81 | $658,376 | |
Mar 21 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 80,000 | Option exercise at $1.30 | $104,000 | |
MMar 21 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 80,000 | Sale at $18.28 | $1,462,376 | |
Mar 14 2006 | KERX | Keryx Biopharmaceuticals Inc | Rose Eric A Md | Director | 5,000 | Option exercise at $11.83 | $59,150 | |
Mar 14 2006 | KERX | Keryx Biopharmaceuticals Inc | Rose Eric A Md | Director | 5,000 | Sale at $18.11 | $90,562 | |
Mar 8 2006 | KERX | Keryx Biopharmaceuticals Inc | Kessel Larry | Director | 75,000 | Option exercise at $1.92 | $144,000 | |
Mar 8 2006 | KERX | Keryx Biopharmaceuticals Inc | Kessel Larry | Director | 75,000 | Sale at $17.20 | $1,290,000 | |
Feb 21 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 40,000 | Option exercise at $1.30 | $52,000 | |
MFeb 21 2006 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | Chairman, CEO | 40,000 | Sale at $16.65 | $665,934 | |
MNov 18 2005 | KERX | Keryx Biopharmaceuticals Inc | Salomon Peter | Director | 11,100 | Sale at $15.00 | $166,500 | |
Nov 21 2005 | KERX | Keryx Biopharmaceuticals Inc | Salomon Peter | Director | 10,000 | Option exercise at $1.92 | $19,200 | |
Nov 16 2005 | KERX | Keryx Biopharmaceuticals Inc | Salomon Peter | Director | 20,000 | Option exercise at $1.92 | $38,400 | |
Nov 16 2005 | KERX | Keryx Biopharmaceuticals Inc | Salomon Peter | Director | 20,000 | Sale at $15.03 | $300,680 | |
Nov 18 2004 | KERX | Keryx Biopharmaceuticals Inc | Salomon Peter | Director | 300 | Purchase at $12.50 | $3,750 | |
Jun 4 2003 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | CEO | 5,000 | Purchase at $1.75 | $8,750 | |
Feb 2 2001 | KERX | Keryx Biopharmaceuticals Inc | Hoenlein Malcolm | Director | 2,000 | Purchase at $9.62 | $19,240 | |
Feb 4 2004 | KERX | Keryx Biopharmaceuticals Inc | Kessel Larry | Director | 4,926 | Other Purchase at $10.15 | $49,999 | |
MNov 22 2004 | KERX | Keryx Biopharmaceuticals Inc | Rosenwald Lindsay A Md | Director, 10% Owner | 83,300 | Sale at $11.65 | $970,357 | |
MNov 17 2004 | KERX | Keryx Biopharmaceuticals Inc | Rosenwald Lindsay A Md | Director, 10% Owner | 111,300 | Sale at $12.84 | $1,429,215 | |
Nov 9 2004 | KERX | Keryx Biopharmaceuticals Inc | Rosenwald Lindsay A Md | Director, 10% Owner | 246,304 | Sale at $11.00 | $2,709,344 | |
Jun 15 2004 | KERX | Keryx Biopharmaceuticals Inc | Salomon Peter | Director | 1,000 | Purchase at $10.80 | $10,800 | |
Jun 15 2004 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | CEO | 5,000 | Purchase at $10.92 | $54,600 | |
MMar 1 2004 | KERX | Keryx Biopharmaceuticals Inc | Rosenwald Lindsay A Md | Director, 10% Owner | 359,604 | Other Purchase at $0.00 | $0 | |
MMar 1 2004 | KERX | Keryx Biopharmaceuticals Inc | Rosenwald Lindsay A Md | Director, 10% Owner | 359,604 | Other Purchase at $0.00 | $0 | |
Jan 29 2004 | KERX | Keryx Biopharmaceuticals Inc | Kash Peter M | Director | 120,000 | Sale at $0.10 | $12,000 | |
MNov 21 2003 | KERX | Keryx Biopharmaceuticals Inc | Weiss Michael S | CEO | 5,000 | Purchase at $4.25 | $21,261 |